Effectiveness of ECP Therapy in Stable Angina Pectoris Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversitas Padjadjaran

About this trial

External Counterpulsation (ECP) is a non-invasive therapy using pressured cuff that is performed on patients with refractory stable angina pectoris to relieve symptoms and increase quality of life. In Indonesia, waiting time for getting coronary artery bypass grafting (CABG) procedure for revascularization treatment in stable angina pectoris patients is way longer than international recommendation which correlates with increase morbidity and mortality during the waiting time. Utilization of ECP for such patients who wait for CABG procedure is still unclear. The investigator aim to evaluate efficacy of addition of ECP compared with medical therapy alone for this population. The efficacy is evaluated using measurement from echocardiography result, treadmill test result, and clinical outcome. if applicable, examination of myocardial perfusion using nuclear examination will also be performed.

Eligibility criteria

Qualifiers

Age >= 18 years old

Diagnosed with stable angina pectoris

Anatomic vessel disease (VD) lesion with 2VD/3VD

Indicated for CABG and in waiting list of CABG procedure; or refuse for CABG and choose medical therapy only; or patients who are decided by the responsible doctor for medical treatment alone because of the high risks of CABG surgery.

Disqualifiers

Congestive Heart Failure

Chronic heart failure with Functional Class NYHA III - IV

LVEF <35%

Unprotected left main stenosis >50%

Trial design

Treatments tested in this trial

  • External Counter Pulsation (ECP) therapy

Treatment groups

84 Participants
are divided into 2 treatment groups

Sponsors and collaborators